Aligos Therapeutics, Inc. Contracts & Agreements
34 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (1)
- Human Resources (18)
- Intellectual Property (4)
- Real Estate (2)
- Uncategorized (1)
- Form of Securities Purchase Agreement, dated October 23, 2023, by and among the Company and the Purchasers (Filed With SEC on October 25, 2023)
- Form of Common Warrant (Filed With SEC on October 25, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 25, 2023)
- Lease Agreement between 601 & 651 GATEWAY CENTER LP and ALIGOS THERAPEUTICS, INC., dated December 9, 2021 (Filed With SEC on March 10, 2022)
- Consulting agreement by and between Aligos Therapeutics, Inc. and Kathleen Glaub, dated June 17, 2021 (Filed With SEC on August 5, 2021)
- Consulting Agreement by and between Aligos Therapeutics, Inc. and Kathy Glaub, dated June 17, 2021 (Filed With SEC on June 28, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 28, 2021)
- Form of Change in Control and Severance Agreement (Filed With SEC on May 10, 2021)
- Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Leonid Beigelman (Filed With SEC on May 10, 2021)
- Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Lawrence M. Blatt (Filed With SEC on May 10, 2021)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Julian Symons, D.Phil., effective as of May 14, 2019 (Filed With SEC on May 10, 2021)
- Description of Securities (Filed With SEC on March 23, 2021)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Lawrence M. Blatt, Ph.D., dated August 16, 2018 (Filed With SEC on October 9, 2020)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on October 9, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on October 9, 2020)
- Confirmatory Employment Letter by and between Aligos Therapeutics, Inc. and Lucinda Quan, J.D., dated May 14, 2019 (Filed With SEC on October 9, 2020)
- Employment Agreement by and between Aligos Therapeutics, Inc. and Leonid Beigelman, Ph.D., dated August 16, 2018 (Filed With SEC on October 9, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on October 9, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 9, 2020)
- Form of Common Stock Certificate (Filed With SEC on October 9, 2020)
- Amended and Restated Investors Rights Agreement dated October 9, 2020 (Filed With SEC on October 9, 2020)
- 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Form of Restricted Stock Unit Award Grant Notice under the 2020 Incentive Award Plan (Filed With SEC on October 9, 2020)
- Aligos Therapeutics/Emory University License Agreement by and between Aligos Therapeutics, Inc. and Emory University, dated June 26, 2018 (Filed With SEC on September 25, 2020)
- Form of International Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- Form of Early Exercise Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- 2018 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2020)
- Lease between Aligos Therapeutics, Inc. and Britannia Biotech Gateway Limited Partnership, dated June 21, 2018 (Filed With SEC on September 25, 2020)
- Amendment to License Agreement by and between Aligos Therapeutics, Inc. and Luxna Biotech Co., Ltd., dated April 8, 2020 (Filed With SEC on September 25, 2020)
- License Agreement by and between Aligos Therapeutics, Inc. and Luxna Biotech Co., Ltd., dated December 19, 2018 (Filed With SEC on September 25, 2020)
- First Amendment to License Agreement by and between Aligos Therapeutics, Inc. and Emory University, dated June 18, 2020 (Filed With SEC on September 25, 2020)
